SML3501

Dehydrocorydaline

≥98% (HPLC)

• Synonym(e): 13-Methylpalmatine, 5,6-Dihydro-2,3,9,10-tetramethoxy-13-methyldibenzo[a,g]quinolizinium
• Empirische Formel (Hill-System): C₂₂H₂₄NO₄
• CAS-Nummer: 30045-16-0
• Molekulargewicht: 366.43
• UNSPSC Code: 41115709
• NACRES: NA.77
• MDL number: MFCD00887635
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: -10 to -25°C
• SMILES string: CC1=C2[N+](CCC3=C2C=C(OC)C(OC)=C3)=CC4=C(OC)C(OC)=CC=C41
• InChI: 1S/C22H24NO4/c1-13-15-6-7-18(24-2)22(27-5)17(15)12-23-9-8-14-10-19(25-3)20(26-4)11-16(14)21(13)23/h6-7,10-12H,8-9H2,1-5H3/q+1
• InChI key: RFKQJTRWODZPHF-UHFFFAOYSA-N

Beschreibung

Biochem/physiol Actions

Alkaloidal isolated from Rhizoma corydalis that exhibits anti-inflammatory, antinociceptive and anti-tumor effects

Dehydrocorydaline is an alkaloidal isolated from Rhizoma corydalis that exhibits anti-inflammatory, antinociceptive and anti-tumor effects. Dehydrocorydaline attenuates bone cancer pain through suppression M1 phenotype and upregulation M2 phenotype of microglia in the spinal cord.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• Was ist los?: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable